Two sides of MGP null arterial disease chondrogenic lesions dependent on transglutaminase 2 and elastin fragmentation associated with induction of adipsin

Journal of Biological Chemistry

Volumn 288, Issue 43, 2013, Pages 31400-31408

  Beazley, Kelly E ^a   Reckard, Steven ^a   Nurminsky, Dmitry ^a   Lima, Florence ^a   Nurminskaya, Maria ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE EXPRESSION ANALYSIS; IMMUNOPRECIPITATIONS; MINERAL DEPOSITIONS; THERAPEUTIC TARGETS; TRANSGLUTAMINASE 2; VASCULAR CALCIFICATION; VASCULAR SMOOTH MUSCLE CELLS; VASCULAR SMOOTH MUSCLES;

AMINO ACIDS; BIOMINERALIZATION; ELASTIN; GENE EXPRESSION; GLYCOPROTEINS; MAMMALS; MUSCLE;

DISEASES;

CALCIUM; CALCIUM BINDING PROTEIN; COMPLEMENT FACTOR D; ELASTASE; ELASTIN; MATRIX GLA PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA MEDIA; ARTICLE; BLOOD VESSEL CALCIFICATION; CHONDROCALCINOSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FRAGMENTATION REACTION; GENE EXPRESSION; GENE MUTATION; IMMUNOPRECIPITATION; LONGEVITY; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WILD TYPE;

ADIPSIN; CALCIFICATION; CARDIOVASCULAR DISEASE; ELASTIN; MATRIX GLA PROTEIN; TRANSGENIC MICE; TRANSGLUTAMINASE 2; VASCULAR SMOOTH MUSCLE CELLS;

ANIMALS; AORTIC DISEASES; CALCIUM-BINDING PROTEINS; COMPLEMENT FACTOR D; ELASTIN; EXTRACELLULAR MATRIX PROTEINS; GTP-BINDING PROTEINS; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; TRANSGLUTAMINASES; VASCULAR CALCIFICATION;

EID: 84886653153     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.495556     Document Type: Article

References (58)

1. Shanahan, C. M., Weissberg, P. L., and Metcalfe, J. C. (1993) Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ. Res. 73, 193-204
2. Boström, K., Zebboudj, A. F., Yao, Y., Lin, T. S., and Torres, A. (2004) Matrix GLA protein stimulates VEGF expression through increased transforming growth factor-α1 activity in endothelial cells. J. Biol. Chem. 279, 52904-52913
3. Crosier, M. D., Booth, S. L., Peter, I., Dawson-Hughes, B., Price, P. A., O'Donnell, C. J., Hoffmann, U., Williamson, M. K., and Ordovas, J. M. (2009) Matrix Gla protein polymorphisms are associated with coronary artery calcification in men. J. Nutr. Sci. Vitaminol. 55, 59-65
4. Herrmann, S. M., Whatling, C., Brand, E., Nicaud, V., Gariepy, J., Simon, A., Evans, A., Ruidavets, J. B., Arveiler, D., Luc, G., Tiret, L., Henney, A., and Cambien, F. (2000) Polymorphisms of the human matrix gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 20, 2386-2393
5. Luo, G., Ducy, P., McKee, M. D., Pinero, G. J., Loyer, E., Behringer, R. R., and Karsenty, G. (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386, 78-81
6. Speer, M. Y., Yang, H. Y., Brabb, T., Leaf, E., Look, A., Lin, W. L., Frutkin, A., Dichek, D., and Giachelli, C. M. (2009) Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ. Res. 104, 733-741
7. Yao, Y., Jumabay, M., Ly, A., Radparvar, M., Cubberly, M. R., and Boström, K. I. (2013) A role for the endothelium in vascular calcification. Circ. Res. 113, 495-504
8. Murshed, M., Schinke, T., McKee, M. D., and Karsenty, G. (2004) Extracellular matrix mineralization is regulated locally. Different roles of two gla-containing proteins. J. Cell Biol. 165, 625-630
9. Price, P. A., Thomas, G. R., Pardini, A. W., Figueira, W. F., Caputo, J. M., and Williamson, M. K. (2002) Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix α-carboxyglutamic acid protein in the serum of etidronate-treated rats. J. Biol. Chem. 277, 3926-3934
10. Price, P. A., Faus, S. A., and Williamson, M. K. (1998) Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler. Thromb. Vasc. Biol. 18, 1400-1407
11. Chatrou, M. L., Reutelingsperger, C. P., and Schurgers, L. J. (2011) Role of vitamin K-dependent proteins in the arterial vessel wall. Hamostaseologie 31, 251-257
12. Zebboudj, A. F., Imura, M., and Boström, K. (2002) Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J. Biol. Chem. 277, 4388-4394
13. Mikhaylova, L., Malmquist, J., and Nurminskaya, M. (2007) Regulation of in vitro vascular calcification by BMP4, VEGF and Wnt3a. Calcif. Tissue Int. 81, 372-381
14. Lomashvili, K. A., Wang, X., Wallin, R., and O'Neill, W. C. (2011) Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification. J. Biol. Chem. 286, 28715-28722
15. Beazley, K. E., Eghtesad, S., and Nurminskaya, M. V. (2013) Quercetin attenuates warfarin-induced vascular calcification in vitro independently from matrix Gla protein. J. Biol. Chem. 288, 2632-2640
16. Khavandgar, Z., Roman, H., Li, J., Lee, S., Vali, H., Brinckmann, J., Davis, E. C., and Murshed, M. (2013) Elastin haploinsufficiency impedes the progression of arterial calcification in MGP-deficient mice. J. Bone Miner. Res. 10.1002/jbmr.2039
17. El-Maadawy, S., Kaartinen, M. T., Schinke, T., Murshed, M., Karsenty, G., and McKee, M. D. (2003) Cartilage formation and calcification in arteries of mice lacking matrix Gla protein. Connect Tissue Res. 44, 272-278
18. Pai, A., Leaf, E. M., El-Abbadi, M., and Giachelli, C. M. (2011) Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. Am. J. Pathol. 178, 764-773
19. Rucker, R. B., Ford, D., Riemann, W. G., and Tom, K. (1974) Additional evidence for the binding of calcium ions to elastin at neutral sites. Calcif. Tissue Res. 14, 317-325
20. Qin, X., Corriere, M. A., Matrisian, L. M., and Guzman, R. J. (2006) Matrix metalloproteinase inhibition attenuates aortic calcification. Arterioscler. Thromb. Vasc. Biol. 26, 1510-1516
21. Aikawa, E., Aikawa, M., Libby, P., Figueiredo, J. L., Rusanescu, G., Iwamoto, Y., Fukuda, D., Kohler, R. H., Shi, G. P., Jaffer, F. A., and Weissleder, R. (2009) Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation 119, 1785-1794
22. Bouvet, C., Moreau, S., Blanchette, J., de Blois, D., and Moreau, P. (2008) Sequential activation of matrix metalloproteinase 9 and transforming growth factor α in arterial elastocalcinosis. Arterioscler. Thromb. Vasc. Biol. 28, 856-862
23. Kaartinen, M. T., Murshed, M., Karsenty, G., and McKee, M. D. (2007) Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice. J. Histochem. Cytochem. 55, 375-386
24. Faverman, L., Mikhaylova, L., Malmquist, J., and Nurminskaya, M. (2008) Extracellular transglutaminase 2 activates α-catenin signaling in calcifying vascular smooth muscle cells. FEBS Lett. 582, 1552-1557
25. Nurminskaya, M., Magee, C., Faverman, L., and Linsenmayer, T. F. (2003) Chondrocyte-derived transglutaminase promotes maturation of preosteoblasts in periosteal bone. Dev. Biol. 263, 139-152
26. Al-Jallad, H. F., Nakano, Y., Chen, J. L., McMillan, E., Lefebvre, C., and Kaartinen, M. T. (2006) Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures. Matrix Biol. 25, 135-148
27. Johnson, K. A., van Etten, D., Nanda, N., Graham, R. M., and Terkeltaub, R. A. (2003) Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy. J. Biol. Chem. 278, 18824-18832
28. Nurminsky, D., Shanmugasundaram, S., Deasey, S., Michaud, C., Allen, S., Hendig, D., Dastjerdi, A., Francis-West, P., and Nurminskaya, M. (2011) Transglutaminase 2 regulates early chondrogenesis and glycosaminoglycan synthesis. Mech Dev 128, 234-245
29. Johnson, K. A., Polewski, M., and Terkeltaub, R. A. (2008) Transglutami-nase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circ. Res. 102, 529-537
30. Beazley, K. E., Deasey, S., Lima, F., and Nurminskaya, M. V. (2012) Transglutaminase 2-mediated activation of α-catenin signaling has a critical role in warfarin-induced vascular calcification. Arterioscler. Thromb. Vasc. Biol. 32, 123-130
31. Beazley, K. E., Banyard, D., Lima, F., Deasey, S. C., Nurminsky, D. I., Konoplyannikov, M., and Nurminskaya, M. V. (2013) Transglutaminase inhibitors attenuate vascular calcification in a preclinical model. Arterioscler. Thromb. Vasc. Biol. 33, 43-51
32. Ishizeki, K., Saito, H., Shinagawa, T., Fujiwara, N., and Nawa, T. (1999) Histochemical and immunohistochemical analysis of the mechanism of calcification of Meckel's cartilage during mandible development in rodents. J. Anat. 194, 265-277
33. Ross, R. (1971) The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J. Cell Biol. 50, 172-186
34. Ashcroft, G. S., Greenwell-Wild, T., Horan, M. A., Wahl, S. M., and Ferguson, M. W. (1999) Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am. J. Pathol. 155, 1137-1146
35. Johnson, K. A., and Terkeltaub, R. A. (2005) External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification. J. Biol. Chem. 280, 15004-15012
36. Li, D. Y., Brooke, B., Davis, E. C., Mecham, R. P., Sorensen, L. K., Boak, B. B., Eichwald, E., and Keating, M. T. (1998) Elastin is an essential determinant of arterial morphogenesis. Nature 393, 276-280
37. Bunton, T. E., Biery, N. J., Myers, L., Gayraud, B., Ramirez, F., and Dietz, H. C. (2001) Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome. Circ. Res. 88, 37-43
38. Wagenseil, J. E., and Mecham, R. P. (2012) Elastin in large artery stiffness and hypertension. J. Cardiovasc. Transl. Res. 5, 264-273
39. Simionescu, A., Simionescu, D. T., and Vyavahare, N. R. (2007) Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-α1. Role of myofibroblasts in vascular calcification. Am. J. Pathol. 171, 116-123
40. Hosaka, N., Mizobuchi, M., Ogata, H., Kumata, C., Kondo, F., Koiwa, F., Kinugasa, E., and Akizawa, T. (2009) Elastin degradation accelerates phosphateinduced mineralization of vascular smooth muscle cells. Calcif. Tissue Int. 85, 523-529
41. Speer, M. Y., Li, X., Hiremath, P. G., and Giachelli, C. M. (2010) Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis. J. Cell. Biochem. 110, 935-947
42. Zhu, L., Wigle, D., Hinek, A., Kobayashi, J., Ye, C., Zuker, M., Dodo, H., Keeley, F. W., and Rabinovitch, M. (1994) The endogenous vascular elastase that governs development and progression of monocrotaline-induced pulmonary hypertension in rats is a novel enzyme related to the serine proteinase adipsin. J. Clin. Invest. 94, 1163-1171
43. Cook, K. S., Min, H. Y., Johnson, D., Chaplinsky, R. J., Flier, J. S., Hunt, C. R., and Spiegelman, B. M. (1987) Adipsin. A circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science 237, 402-405
44. Flier, J. S., Cook, K. S., Usher, P., and Spiegelman, B. M. (1987) Severely impaired adipsin expression in genetic and acquired obesity. Science 237, 405-408
45. Xu, Y., Ma, M., Ippolito, G. C., Schroeder, H. W., Jr., Carroll, M. C., and Volanakis, J. E. (2001) Complement activation in factor D-deficient mice. Proc. Natl. Acad. Sci. 98, 14577-14582
46. White, R. T., Damm, D., Hancock, N., Rosen, B. S., Lowell, B. B., Usher, P., Flier, J. S., and Spiegelman, B. M. (1992) Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J. Biol. Chem. 267, 9210-9213
47. Choy, L. N., Rosen, B. S., and Spiegelman, B. M. (1992) Adipsin and an endogenous pathway of complement from adipose cells. J. Biol. Chem. 267, 12736-12741
48. Rosen, B. S., Cook, K. S., Yaglom, J., Groves, D. L., Volanakis, J. E., Damm, D., White, T., and Spiegelman, B. M. (1989) Adipsin and complement factor D activity. An immune-related defect in obesity. Science 244, 1483-1487
49. Shields, K. J., Stolz, D., Watkins, S. C., and Ahearn, J. M. (2011) Complement proteins C3 and C4 bind to collagen and elastin in the vascular wall. A potential role in vascular stiffness and atherosclerosis. Clin. Transl. Sci. 4, 146-152
50. Ruan, C. C., Zhu, D. L., Chen, Q. Z., Chen, J., Guo, S. J., Li, X. D., and Gao, P. J. (2010) Perivascular adipose tissue-derived complement 3 is required for adventitial fibroblast functions and adventitial remodeling in deoxycorticosterone acetate-salt hypertensive rats. Arterioscler. Thromb. Vasc. Biol. 30, 2568-2574
51. Pimanda, J. E., Donaldson, I. J., de Bruijn, M. F., Kinston, S., Knezevic, K., Huckle, L., Piltz, S., Landry, J. R., Green, A. R., Tannahill, D., and Göttgens, B. (2007) The SCL transcriptional network and BMP signaling pathway interact to regulate RUNX1 activity. Proc. Natl. Acad. Sci. U. S. A. 104, 840-845
52. Yao, Y., Jumabay, M., Wang, A., and Boström, K. I. (2011) Matrix Gla protein deficiency causes arteriovenous malformations in mice. J. Clin. Invest. 121, 2993-3004
53. Schurgers, L. J., Spronk, H. M., Skepper, J. N., Hackeng, T. M., Shanahan, C. M., Vermeer, C., Weissberg, P. L., and Proudfoot, D. (2007) Post-translational modifications regulate matrix Gla protein function. Importance for inhibition of vascular smooth muscle cell calcification. J. Thromb. Haemost. 5, 2503-2511
54. O'Young, J., Liao, Y., Xiao, Y., Jalkanen, J., Lajoie, G., Karttunen, M., Goldberg, H. A., and Hunter, G. K. (2011) Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals. J. Am. Chem. Soc. 133, 18406-18412
55. Yao, Y., Shahbazian, A., and Boström, K. I. (2008) Proline and α-carboxylated glutamate residues in matrix Gla protein are critical for binding of bone morphogenetic protein-4. Circ. Res. 102, 1065-1074
56. Dao, H. H., Essalihi, R., Graillon, J. F., Larivière, R., De Champlain, J., and Moreau, P. (2002) Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension. J. Hypertens. 20, 1597-1606
57. Boström, K. I., Jumabay, M., Matveyenko, A., Nicholas, S. B., and Yao, Y. (2011) Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circ. Res. 108, 446-457
58. Sharma, B., and Albig, A. R. (2013) Matrix Gla protein reinforces angiogenic resolution. Microvasc. Res. 85, 24-33